M. Kowalski

Journal of the American Medical Association (JAMA) · 2005

A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Whom M. Kowalski trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Eric J. Topol

Who trusts M. Kowalski overall

  1. M. Gheorghiade

Papers from M. Kowalski's perspective

Ordered by how strongly the researchers M. Kowalski trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group. (New England Journal of Medicine)
  2. Risk of Worsening Renal Function With Nesiritide in Patients With Acutely Decompensated Heart Failure (Circulation)
  3. Failing the public health--rofecoxib, Merck, and the FDA. (New England Journal of Medicine)
  4. Blood transfusion in elderly patients with acute myocardial infarction. (New England Journal of Medicine)
  5. Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases? (Critical Care Medicine)
  6. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. (New England Journal of Medicine)
  7. Peripheral arterial disease detection, awareness, and treatment in primary care. (Journal of the American Medical Association (JAMA))
  8. Improving language models by retrieving from trillions of tokens
  9. Potential Liability for Physicians Using Artificial Intelligence.
  10. Unified rational protein engineering with sequence-based deep representation learning

Their papers